208 related articles for article (PubMed ID: 2472826)
1. Medical treatment of neuroendocrine gut and pancreatic tumors.
Oberg K; Eriksson B
Acta Oncol; 1989; 28(3):425-31. PubMed ID: 2472826
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
di Bartolomeo M; Bajetta E; Buzzoni R; Mariani L; Carnaghi C; Somma L; Zilembo N; di Leo A
Cancer; 1996 Jan; 77(2):402-8. PubMed ID: 8625251
[TBL] [Abstract][Full Text] [Related]
3. Interferons alone or in combination with chemotherapy or other biologicals in the treatment of neuroendocrine gut and pancreatic tumors.
Oberg K; Eriksson B; Janson ET
Digestion; 1994; 55 Suppl 3():64-9. PubMed ID: 7698540
[TBL] [Abstract][Full Text] [Related]
4. Treatment of neuroendocrine gut and pancreatic tumors with interferons.
Oberg K
Acta Chir Scand Suppl; 1989; 549():56-62. PubMed ID: 2538982
[No Abstract] [Full Text] [Related]
5. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours.
Oberg K
Ann Oncol; 2001; 12 Suppl 2():S111-4. PubMed ID: 11762335
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.
Saltz L; Kemeny N; Schwartz G; Kelsen D
Cancer; 1994 Aug; 74(3):958-61. PubMed ID: 8039124
[TBL] [Abstract][Full Text] [Related]
7. Interferons in the management of neuroendocrine tumors and their possible mechanism of action.
Oberg K
Yale J Biol Med; 1992; 65(5):519-29; discussion 531-6. PubMed ID: 1340065
[TBL] [Abstract][Full Text] [Related]
8. Nonsurgical treatment of advanced malignant neuroendocrine pancreatic tumors and midgut carcinoids.
Skogseid B
World J Surg; 2001 Jun; 25(6):700-3. PubMed ID: 11376401
[TBL] [Abstract][Full Text] [Related]
9. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.
Eriksson BK; Larsson EG; Skogseid BM; Löfberg AM; Lörelius LE; Oberg KE
Cancer; 1998 Dec; 83(11):2293-301. PubMed ID: 9840528
[TBL] [Abstract][Full Text] [Related]
10. Novel therapy for the treatment of human carcinoid.
Evers BM; Hurlbut SC; Tyring SK; Townsend CM; Uchida T; Thompson JC
Ann Surg; 1991 May; 213(5):411-6. PubMed ID: 1708983
[TBL] [Abstract][Full Text] [Related]
11. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
Gorden P; Comi RJ; Maton PN; Go VL
Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors.
Frank M; Klose KJ; Wied M; Ishaque N; Schade-Brittinger C; Arnold R
Am J Gastroenterol; 1999 May; 94(5):1381-7. PubMed ID: 10235222
[TBL] [Abstract][Full Text] [Related]
13. An update of the medical treatment of malignant endocrine pancreatic tumors.
Eriksson B; Oberg K
Acta Oncol; 1993; 32(2):203-8. PubMed ID: 8391832
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine gastrointestinal tumors--a condensed overview of diagnosis and treatment.
Oberg K
Ann Oncol; 1999; 10 Suppl 2():S3-8. PubMed ID: 10399026
[TBL] [Abstract][Full Text] [Related]
15. Endocrine tumors of the gastrointestinal tract: systemic treatment.
Oberg K
Anticancer Drugs; 1994 Oct; 5(5):503-19. PubMed ID: 7858282
[TBL] [Abstract][Full Text] [Related]
16. Efficient symptomatic control of carcinoid tumors with somatostatin in patients with disease progression under alpha-interferon therapy.
Boehme MW; Schmidt-Gayk H; Bihl H; Eisenhut M; Herfarth CH; Kommere B; Raeth U
Hepatogastroenterology; 1995; 42(6):1053-61. PubMed ID: 8847018
[TBL] [Abstract][Full Text] [Related]
17. Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy.
Kvols LK
Am J Med; 1986 Dec; 81(6B):49-55. PubMed ID: 2432781
[TBL] [Abstract][Full Text] [Related]
18. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
Strosberg JR; Choi J; Cantor AB; Kvols LK
Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
[TBL] [Abstract][Full Text] [Related]
19. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
Skinazi F; Zins M; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):673-8. PubMed ID: 8853257
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine gastrointestinal tumours.
Oberg K
Ann Oncol; 1996 Jul; 7(5):453-63. PubMed ID: 8839899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
